Search - tctmd.com

Displaying 21 - 40 of 221

Sort: Relevancy | Date

News

‘Less Is More’ for Patients With AF and Stable CAD: AFIRE Analysis

Todd Neale

June 17, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

Age and Fitness Biggest Predictors of Mortality in CAD Patients, AI Study Shows

Michael O'Riordan

May 04, 2022

News Conference News ACC 2022

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

Michael O'Riordan

April 07, 2022

News Conference News ACC 2022

In ANOCA, Diltiazem Fails to Improve Vasomotor Function: EDIT-CMD

Caitlin E. Cox

April 02, 2022

Presentation SCAD 2022

MINOCA: Causes and Investigation Algorithm

Presenter: Janet Wei

February 19, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

News Daily News

Another Study Links Stopping Statins to MACE in the Elderly

Shelley Wood

December 03, 2021

News Daily News

No Uptick in CVD Events After COVID-19 Vaccination in Older Adults

Michael O'Riordan

November 29, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Caitlin E. Cox

October 11, 2021

News Daily News

Women Stand to Gain the Most From Standardized STEMI Protocols

Michael O'Riordan

September 30, 2021

News Daily News

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Michael O'Riordan

August 26, 2021

News Daily News

Meta-analysis Affirms Colchicine’s Myriad CV Benefits

Caitlin E. Cox

April 12, 2021

News Daily News

MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost

Michael O'Riordan

March 04, 2021

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Todd Neale

February 08, 2021

News Daily News

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

Todd Neale

February 01, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

Microvascular Thrombi Common in Patients Dying of COVID-19

Michael O'Riordan

January 27, 2021

Advertisement

‘Less Is More’ for Patients With AF and Stable CAD: AFIRE Analysis

Good News and Bad for High-Intensity Statin Use in ASCVD

Age and Fitness Biggest Predictors of Mortality in CAD Patients, AI Study Shows

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

In ANOCA, Diltiazem Fails to Improve Vasomotor Function: EDIT-CMD

MINOCA: Causes and Investigation Algorithm

January 2022 News Roundup

British Medical Groups Express Concern About Inclisiran Rollout

Another Study Links Stopping Statins to MACE in the Elderly

No Uptick in CVD Events After COVID-19 Vaccination in Older Adults

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Women Stand to Gain the Most From Standardized STEMI Protocols

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Meta-analysis Affirms Colchicine’s Myriad CV Benefits

MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Microvascular Thrombi Common in Patients Dying of COVID-19

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content